Retraction Note: Cardiac findings in a phase II double-blind randomized placebo-controlled trial of combination therapy (HAZDPac) to treat COVID-19 patients
Saved in:
| Main Authors: | Sabine Hazan, Adriana C. Vidal, Nicolas Hulscher, Amelia Goudzwaard, Peter A. McCullough, Alon A. Steinberg |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-02-01
|
| Series: | BMC Cardiovascular Disorders |
| Online Access: | https://doi.org/10.1186/s12872-025-04554-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Retraction Note: Detection of SARS-CoV-2 from patient fecal samples by whole genome sequencing
by: Andreas Papoutsis, et al.
Published: (2025-05-01) -
Reading through the eyes of a university student: A double-masked randomised placebo-controlled cross-over protocol investigating coloured spectacle lens efficacy in adults with visual stress.
by: Darragh Liam Harkin, et al.
Published: (2025-01-01) -
Double-blind clonazepam vs placebo in panic disorder treatment
by: ALEXANDRE MARTINS VALENÇA, et al.
Published: (2000-12-01) -
Double-Blind, Placebo-Controlled Study of Myotoxicity and Neurotoxicity of Bupivacaine in Rats
by: R. E. Lakhin, et al.
Published: (2019-11-01) -
RETRACTED ARTICLE: Detection of SARS-CoV-2 from patient fecal samples by whole genome sequencing
by: Andreas Papoutsis, et al.
Published: (2021-01-01)